CIK 0001217234 · Large accelerated filer
CareDx, Inc.
Sign in to watch- Ticker
- CDNA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943316839
- Phone
- 415-287-2300
- Business address
- 8000 MARINA BLVD, 4TH FLOOR, BRISBANE, CA, 94005
- Former names
- XDx, Inc., EXPRESSION DIAGNOSTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,154,003
- in 2 filings, $5.2M under 10b5-1 plans
Net −$5,154,003. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-02 | Novack Jeffrey Adam Secretary and General Counsel | Shares withheld for taxes | −2,492 | $20.42 | $51K | 132,775 |
| 2026-02-02 | Novack Jeffrey Adam Secretary and General Counsel | Shares withheld for taxes | −2,970 | $20.42 | $61K | 129,805 |
| 2026-02-02 | Hanna John Walter JR President and CEO | Grant or award | +162,500 | 759,905 | ||
| 2026-02-02 | Hanna John Walter JR President and CEO | Grant or award | +37,632 | 797,537 | ||
| 2026-02-02 | Hanna John Walter JR President and CEO | Shares withheld for taxes | −13,694 | $20.42 | $280K | 783,843 |
| 2026-02-02 | Kennedy Keith Chief Operating Officer | Grant or award | +60,000 | 199,309 | ||
| 2026-02-02 | Kennedy Keith Chief Operating Officer | Grant or award | +14,474 | 213,783 | ||
| 2026-02-02 | Kennedy Keith Chief Operating Officer | Shares withheld for taxes | −4,644 | $20.42 | $95K | 209,139 |
| 2026-01-22 | Hanna John Walter JR President and CEO | Sale 10b5-1 | −19,280 | $21.16 | $408K | 597,405 |
| 2026-01-21 | Hanna John Walter JR President and CEO | Sale 10b5-1 | −200 | $21.00 | $4K | 616,685 |
| 2026-01-15 | Hanna John Walter JR President and CEO | Sale 10b5-1 | −10,156 | $21.05 | $214K | 616,885 |
| 2026-01-06 | Goldberg Michael Director | Grant or award | +1,492 | 157,461 | ||
| 2025-12-04 | Novack Jeffrey Adam Secretary and General Counsel | Sale | −7,007 | $19.15 | $134K | 98,211 |
| 2025-12-04 | Novack Jeffrey Adam Secretary and General Counsel | Sale | −286 | $19.75 | $6K | 97,925 |
| 2025-11-07 | Novack Jeffrey Adam Secretary and General Counsel | Sale | −2,688 | $15.52 | $42K | 105,218 |
| 2025-11-06 | Novack Jeffrey Adam Secretary and General Counsel | Shares withheld for taxes | −2,152 | $15.01 | $32K | 107,906 |
| 2025-11-01 | Novack Jeffrey Adam Secretary and General Counsel | Shares withheld for taxes | −2,872 | $14.77 | $42K | 110,058 |
| 2025-10-22 | Gunasekaran Suresh Director | Grant or award | +27,453 | 27,453 | ||
| 2025-10-06 | Goldberg Michael Director | Grant or award | +1,753 | 155,969 | ||
| 2025-09-12 | Meng Jessica Chief Commercial Officer | Shares withheld for taxes | −4,703 | $13.53 | $64K | 109,629 |
Page 6 of 17 · 324 trades